Company

CLAIRIgene

Biotechnology Research The Multitude of Effects of Alzheimer's Disease? Stop by Our Poster at Ctad Clinical Trials on Alzheimer's Disease. 3 employees

Employees: 3
Contacts: 2
Emails: 2
Phones: 2

clairigene.com LinkedIn

CLAIRIgene Overview

Headquarters: The Multitude of Effects of Alzheimer's Disease? Stop by Our Poster at Ctad Clinical Trials on Alzheimer's Disease.
Website: clairigene.com
Industry: Biotechnology Research
Employees: 3
Founded: 2019
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

gene therapy neurodegeneration epigenome editing gene therapy manufacturing CNS CNS organoids

About CLAIRIgene

CLAIRIgene is developing novel epigenome-targeted gene therapy for unmet medical needs in CNS disorders. Our goal is to intercept gene expression to halt the progression of devastating neurodegenerative diseases like Alzheimer's Disease, Parkinson's, and Lewy Body Dementia.

CLAIRIgene Contact Details

People in AeroLeads: 2
With contact data: 2
Email contacts: 2; 100.0% coverage
Phone contacts: 2; 100.0% coverage

CLAIRIgene Org Chart

Sample employees and titles

Name	Title	Location	Contact
Boris Kantor	Professor of Biomedical Sciences	Chapel Hill, North Carolina, United States	Email Phone
Ornit Chiba-Falek	Professor and Division Chief at Duke	Chapel Hill, North Carolina, United States	Email Phone